Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

5 Best- And Worst-Performing Mega-Cap Stocks In July 2022

By ValueWalkStock MarketsAug 02, 2022 01:00AM ET
www.investing.com/analysis/5-best-and-worstperforming-megacap-stocks-in-july-2022-200627928
5 Best- And Worst-Performing Mega-Cap Stocks In July 2022
By ValueWalk   |  Aug 02, 2022 01:00AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

After a dismal performance in the first six months of 2022, July offered some respite for stock market investors. In fact, July has been the best month for the S&P 500 since November 2020. The index gained more than 9% last month, and all of the top mega-cap stocks offered decent returns to investors. Let’s take a look at the five best- and worst-performing mega-cap stocks in July 2022.

The Five Best-Performing Mega-Cap Stocks In July 2022

We have used the July return data for mega-cap stocks from finviz.com to rank the five best- and worst-performing mega-cap stocks in July 2022. Let’s start with the five best-performing mega-cap stocks in July 2022:

5. Danaher (15%)

Founded in 1984 and headquartered in Washington, D.C., Danaher (NYSE:DHR) is a medical company that develops professional, medical, industrial, and commercial products and services. The shares have lost almost 12% year to date and are down more than 2% in the last year. As of the time of this writing, the company's shares are trading at more than $290. They have a 52-week range of $233.71 to $333.96. Danaher reported more than $29 billion in revenue for 2021 and over $22 billion in 2020.

4. Apple (17%)

Founded in 1976 and headquartered in Cupertino, California, Apple (NASDAQ:AAPL) develops and sells smartphones, tablets, wearables, computers, and related services and software. The shares have lost more than 8% year to date but are up by almost 12% in the last year. As of the time of this writing, it is trading at above $162, and their 52-week range is $129.04 to $182.94. Apple reported more than $360 billion in revenue for 2021 and over $270 billion in 2020.

3. NVIDIA (17%)

Founded in 1993 and headquartered in Santa Clara, California, NVIDIA (NASDAQ:NVDA) is a computing platform company that develops graphics-processor technologies for workstations, desktop computers, and mobile devices. The shares have lost almost 36% year to date and are down by over 7% in the last year. As of the time of this writing, the chipmaker's shares are trading at above $184 with a 52-week range of $140.55 to $346.47. NVIDIA reported more than $26 billion in revenue for 2021 and over $16 billion in 2020.

2. Amazon (24%)

Founded in 1994 and headquartered in Seattle, Washington, Amazon (NASDAQ:AMZN) is an e-commerce company that also serves developers and enterprises through Amazon Web Services. The shares have lost more than 18% year to date and are down by almost 18% in the last year. As of the time of this writing, the company's shares are trading at above $136, and their 52-week range is $101.26 to $188.11. Amazon reported more than $460 billion in revenue for 2021 and over $380 billion in 2020.

1. Tesla (30%)

Founded in 2003 and headquartered in Austin, Texas, Tesla (NASDAQ:TSLA) develops and sells fully electric vehicles and energy generation and storage systems. The shares have lost almost 13% year to date but have gained almost 30% in the last year. As of the time of this writing, the company's shares are trading at above $923 with a 52-week range of $620.57 to $1,243.49. Tesla reported more than $53 billion in revenue for 2021 and over $31 billion in 2020.

The Five Worst-Performing Mega-Cap Stocks In July 2022

Here are the five worst-performing mega-cap stocks in July 2022:

5. Johnson & Johnson (-1%)

Founded in 1886 and headquartered in Brunswick, New Jersey Johnson & Johnson (NYSE:JNJ) develops and sells healthcare products. The shares have gained almost 2% year to date and are up by almost 1% in the last year. As of the time of this writing, it is trading at above $173 with a 52-week range of $155.72 to $186.69. Johnson & Johnson reported more than $90 billion in revenue for 2021 and over $80 billion in 2020.

4. Procter & Gamble (-2%)

Founded in 1837 and headquartered in Cincinnati, Ohio, Procter & Gamble (NYSE:PG) is a consumer goods company that offers products and services for various rooms, including kitchens, laundry rooms, bathrooms and more. The shares have lost almost 14% year to date and are down by almost 1% in the last year. As of the time of this writing, it is trading at above $140 with a 52-week range of $129.50 to $165.35. Procter & Gamble reported more than $76 billion in revenue for 2021 and over $70 billion in 2020.

3. Meta Platforms (-3%)

Founded in 2004 and headquartered in Menlo Park, California, Meta Platforms (NASDAQ:META) develops and operates social media apps. The shares have lost more than 52% year to date and are down by almost 55% in the last year. As of the time of this writing, it is trading at above $159 with a 52-week range of $154.25 to $384.33. Meta Platforms reported more than $110 billion in revenue for 2021 and over $80 billion in 2020.

2. Merck & Co. (-3%)

Founded in 1891 and headquartered in Kenilworth, New Jersey, Merck (NYSE:MRK) offers health solutions through its prescription medicines, animal health products, vaccines, biologic therapies and consumer care product lines. The shares have gained almost 16% year to date and are up by over 16% in the last year. As of the time of this writing, it is trading at above $88 with a 52-week range of $70.89 to $95.72. Merck reported more than $48 billion in revenue for 2021 and over $41 billion in 2020.

1. AbbVie (-7%)

Founded in 2011 and headquartered in North Chicago, Illinois, AbbVie (NYSE:ABBV) is a biopharmaceutical company that focuses on developing and selling pharmaceutical products that treat conditions such as chronic autoimmune diseases. The shares have gained more than 4% year to date and are up by over 22% in the last year. As of the time of this writing, the company's shares are trading at above $140 with a 52-week range of $105.56 to $175.91. AbbVie reported more than $56 billion in revenue for 2021 and over $45 billion in 2020.

5 Best- And Worst-Performing Mega-Cap Stocks In July 2022
 

Related Articles

5 Best- And Worst-Performing Mega-Cap Stocks In July 2022

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email